TrialOncotarget2024

Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.

Alexandra Jackovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.